The board of China First Capital Group Limited announced that Dr. Du Xiaotang has been appointed as an independent non-executive Director and a member of the Audit Committee and the Remuneration Committee with effect from 19 July 2019. The board announced that Ms. Li Dan, an executive Director, has resigned as an executive Director and a member of the Remuneration Committee and the Nomination Committee with effect from 19 July 2019, due to her intention to devote more time to her family. The company also announced that the office of Dr. Li as an independent non-executive Director has been vacated on July 19, 2019 and he ceased to be a member of the Audit Committee, the Remuneration Committee, the Nomination Committee and the Strategy Committee with effect from July 19, 2019. Dr. Li has been absent from meetings of the Board for a continuous period of more than six months without special leave of absence from the Board, and has not appointed any alternate Director to attend meetings in his stead. In light of this situation, the Board held a meeting on July 19, 2019 and resolved that the office of Dr. Li as an independent non-executive Director be vacated with immediate effect. Dr. Li also ceased to be a member of the Audit Committee, the Remuneration Committee, the Nomination Committee and the Strategy Committee with effect from July 19, 2019.